Press Releases
July 13, 2017DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES CLOSING OF PRIVATE PLACEMENT
July 7, 2017DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES GRANT OF OPTIONS
June 22, 2017DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES PLANS FOR ITS DERMATOLOGY PROGRAM OF THYKAMINE
June 21, 2017DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES ISSUANCE OF ONE NEW KEY PATENT AND THE GRANTING OF A TRADEMARK
May 18, 2017DEVONIAN HEALTH GROUP INC.- LISTING OF ITS SHARES ON THE TSX VENTURE EXCHANGE
April 27, 2017ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – END OF ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING
February 3, 2017ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – RECEIPT FOR ITS AMENDED AND RESTATED PROSPECTUS
November 25, 2016ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – RESULTS OF THE VOTES FROM THE ANNUAL GENERAL MEETING OF ORLETTO
November 9, 2016ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – RESULTS OF THE VOTES FROM THE ANNUAL GENERAL MEETING OF DEVONIAN
November 7, 2016ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – DEVONIAN APPOINTS DR JEAN-CLAUDE TARDIF AS CHAIRMAN OF SCIENTIFIC ADVISORY BOARD
August 23, 2016ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – FINANCING BY WAY OF LONG FORM PROSPECTUS
April 26, 2016ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – AGREEMENT IN PRINCIPLE
May 20, 2015ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – AGREEMENT IN PRINCIPLE
